Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Gottesdiener currently holds 48,445 shares of Apogee Therapeutics, Inc. (APGE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Gottesdiener has been a net neutral trader of APGE stock. They have purchased $0 and sold $0 worth of shares.
Andrew Gottesdiener's most recent insider trade was on Sep 9, 2026, when they sold 48,445 shares at $0.00 per share.
Andrew Gottesdiener serves as Executive at Apogee Therapeutics, Inc. (APGE). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Andrew Gottesdiener holds the position of Executive at Apogee Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Andrew Gottesdiener has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Andrew Gottesdiener was on Sep 9, 2026, when they purchased $0 worth of KRSA shares. This transaction involved 48,445 shares at N/A per share.
Andrew Gottesdiener currently owns 48,445 shares of Apogee Therapeutics, Inc. (APGE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Gottesdiener's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Gottesdiener has 2 Form 4 filings on record as an insider at Apogee Therapeutics, Inc..
Set alerts for Andrew Gottesdiener and 40,000+ other insiders.